ArticleNature cardiovascular research2026

Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy.

Stephanie Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.